Taylor Ben R 4

What Happened Ben R. Taylor, Chief Financial Officer of Recursion Pharmaceuticals (RXRX), had 5,396 restricted stock unit (RSU) shares withheld to cover tax withholding in a net settlement. The shares were valued at $3.15 each, for a total of approximately $16,997. This was a tax-withholding disposition (transaction code F), not an open-market sale or purchase.

Key Details

• Transaction date: 2026-06-15
• Filing date: 2026-06-17 (filed within the typical 2-business-day window)
• Disposition: 5,396 shares withheld @ $3.15 = $16,997 (reported as "F")
• Shares owned after transaction: Not disclosed in the provided filing excerpt
• Footnote: F1 — shares were withheld by the issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units

Context This was a routine net-share settlement to cover tax obligations when RSUs vested — a common administrative action that does not necessarily indicate the insider is reducing exposure or expressing a view on the stock. For investors tracking insider activity, direct purchases tend to be more informative than tax-withholding or routine dispositions.